Abstract
Development of Candida spp. biofilms on medical devices such as catheters and voice prosthesis has been recognized as an increasing clinical problem. Simple device removal is often impossible, while in addition, resulting candidal infections are difficult to resolve due to their increased resistance to many antifungal agents. Susceptibility studies of clinical isolates are generally performed according to the CLSI standard, which measures planktonic cell susceptibility, but similar standards have not been designed or applied to testing of cells growing within a biofilm. As consistent biofilms from many strains are more difficult to simultaneously obtain and analyze than are independent planktonic cultures, any standard assay must address these concerns. In the present chapter, optimized conditions that promote biofilm formation within individual wells of microtiter plates are described. In addition, the method has proven useful in preparing C. albicans biofilms for investigation by a variety of microscopic and molecular techniques.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Douglas, L. J. (2002) Medical importance of biofilms in Candida infections. Rev. Iberoam. Micol. 19, 139–143.
Kojic, E. M., and Darouiche R. O. (2004) Candida infections of medical devices. Clin. Microbiol. Rev. 17, 255–267.
Krom, B. P., Cohen, J. B., McElhaney Feser, G. E., and Cihlar, R. L. (2007) Optimized candidal biofilm microtiter assay. J. Microbiol. Methods. 68(2), 421–423.
Fonzi, W. A., and Irwin, M. Y. (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134, 717–728.
Staab, J. F., Bahn, Y. S., and Sundstrom, P. (2003) Integrative, multifunctional plasmids for hypha-specific or constitutive expression of green fluorescent protein in Candida albicans. Microbiology 149, 2977–2986.
NCCLS. (2002) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard—Second Edition. NCCLS document M27-A2. NCCLS, Wayne, Pennsylvania, USA.
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., and Ghannoum, M. A. (2001). Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183, 5385–5394.
Al Fattani, M. A., and Douglas, L. J. (2006) Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J. Med. Microbiol. 55, 999–1008.
Hawser, S. P., Norris, H., Jessup, C. J., and Ghannoum, M. A. (1998). Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J. Clin. Microbiol. 36, 1450–1452.
Kuhn, D. M., Balkis, M., Chandra, J., Mukherjee, P. K., and Ghannoum, M. A. (2003). Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J. Clin. Microbiol. 41, 506–508.
Hawser, S. P., Baillie, G. S., and Douglas, L. J. (1998) Production of extracellular matrix by Candida albicans biofilms. J. Med. Microbiol. 47, 253–256.
Baillie, G. S., and Douglas, L. J. (2000). Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 46, 397–403.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Krom, B.P., Cohen, J.B., McElhaney-Feser, G., Busscher, H.J., van der Mei, H.C., Cihlar, R.L. (2009). Conditions for Optimal Candida Biofilm Development in Microtiter Plates. In: Cihlar, R.L., Calderone, R.A. (eds) Candida albicans. Methods in Molecular Biology, vol 499. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-151-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-60327-151-6_7
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-760-0
Online ISBN: 978-1-60327-151-6
eBook Packages: Springer Protocols